What is Assembly Biosciences's net change in cash?

Assembly Biosciences (ASMB) reported net change in cash of -$27.33M in Q1 2026.

How has Assembly Biosciences's net change in cash changed year-over-year?

Assembly Biosciences's net change in cash decreased by 83.0% year-over-year, from -$14.93M to -$27.33M.

What is the long-term trend for Assembly Biosciences's net change in cash?

Over 2 years (2021 to 2025), Assembly Biosciences's net change in cash has grown at a 20.6% compound annual growth rate (CAGR), from -$13.82M to $20.11M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Assembly Biosciences ASMB Net Change in Cash

Net Change in Cash at other companies

Arrowhead ResearchARWR

-$14.12M-111%

ALN

Alnylam PharmaceuticalsALNY

$53.61M0.0%

Avalo TherapeuticsAVTX

$9.21M+197%

Arbutus Biopharma CorporationABUS

$5.7M+664%

Vir Biotechnology, Inc.VIR

$41.97M-14.9%

Maravai LifeSciences Holdings, Inc.MRVI

-$50.97M-36.5%

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's net change in cash?: Assembly Biosciences (ASMB) reported net change in cash of -$27.33M in Q1 2026.
How has Assembly Biosciences's net change in cash changed year-over-year?: Assembly Biosciences's net change in cash decreased by 83.0% year-over-year, from -$14.93M to -$27.33M.
What is the long-term trend for Assembly Biosciences's net change in cash?: Over 2 years (2021 to 2025), Assembly Biosciences's net change in cash has grown at a 20.6% compound annual growth rate (CAGR), from -$13.82M to $20.11M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.